Panbela Therapeutics’ (PBLA) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their neutral rating on shares of Panbela Therapeutics (NASDAQ:PBLA – Free Report) in a research report sent to investors on Thursday, Benzinga reports. HC Wainwright also issued estimates for Panbela Therapeutics’ Q3 2024 earnings at ($1.63) EPS, Q4 2024 earnings at ($1.61) EPS, FY2024 earnings at ($6.76) EPS, FY2025 earnings at ($4.44) […]
More Stories
Heidelberg Materials (ETR:HEI) Shares Cross Above 200 Day Moving Average – Time to Sell?
Heidelberg Materials AG (ETR:HEI – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday...
John Seaman Acquires 25,000 Shares of i-80 Gold Corp. (TSE:IAU) Stock
i-80 Gold Corp. (TSE:IAU – Get Free Report) Director John Seaman bought 25,000 shares of the company’s stock in a...
Short Interest in The Swatch Group AG (OTCMKTS:SWGNF) Increases By 36.1%
The Swatch Group AG (OTCMKTS:SWGNF – Get Free Report) was the recipient of a large increase in short interest in...
North Midland Construction (LON:NMD) Share Price Passes Below 200 Day Moving Average – What’s Next?
North Midland Construction PLC (LON:NMD – Get Free Report)’s stock price crossed below its 200-day moving average during trading on...
Portmeirion Group (LON:PMP) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Portmeirion Group PLC (LON:PMP – Get Free Report)’s share price crossed above its two hundred day moving average during trading...
Supermarket Income REIT plc (OTCMKTS:SUPIF) Short Interest Update
Supermarket Income REIT plc (OTCMKTS:SUPIF – Get Free Report) was the recipient of a significant growth in short interest in...